                         SEQUENCE LISTING

<110>  Palatin Technologies, Inc.
       Shi, Yi-Qun
       Sharma, Shubh D.
       Yang, Wei
       Chen, Xin
 
<120>  Melanocortin Receptor-Specific Peptides for Treatment of Sexual 
       Dysfunction

<130>  0906-097

<150>  61/059,910
<151>  2008-06-09

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  1

Xaa Asp His Xaa Arg Trp Lys 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide drived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<400>  2

Xaa Asp His Xaa Arg Trp Lys 
1               5           


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin receptor binding core sequence derived 
       from alpha-MSH

<400>  3

His Phe Arg Trp 
1               


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin receptor binding peptide of the invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  4

Arg Asp Xaa Xaa Arg Trp Lys 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin receptor binding peptide of the invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<400>  5

Arg Asp Xaa Xaa Arg Trp Lys 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin receptor binding peptide of the invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  6

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin receptor binding peptide of the invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  7

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding sequence derived from human 
       alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  8

Ser Tyr Ser Met Glu His Phe Arg Trp Gly Lys Pro Val 
1               5                   10              


<210>  9
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding sequence derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  9

Ser Tyr Ser Xaa Glu His Xaa Arg Trp Gly Lys Pro Val 
1               5                   10              


